Creators and Guests

With over 30 years in creative marketing and visual storytelling, I’ve built a career on turning ideas into impact. From brand transformation to media production, podcast development, and outreach strategies, I craft compelling narratives that don’t just capture attention—they accelerate growth and drive measurable results.

Aimee Taylor is the founder and CEO of Alt Digital Marketing, a company that specializes in medical marketing with particular emphasis on the aesthetics industry. Aimee has over 13 years of digital marketing experience, which is bolstered by two decades of broadcast TV sales. She has a deep understanding of all aspects of digital and traditional marketing. She has a BA in Telecommunications from Indiana University, Bloomington, IN.

Dan Goldberger is a highly accomplished C-level executive with over 25 years of leadership experience, known for driving revenue growth and organizational success in the life sciences and healthcare sectors. He has built a strong reputation for leading turnaround initiatives, cultivating high-performance cultures, and spearheading product innovation in competitive, highly regulated industries including biotech, high tech, and medical technology. While his résumé outlines an impressive history of roles and achievements, it does not fully capture the perseverance and dedication he brings to every opportunity. A lifelong contributor to the life sciences and healthcare space, Dan is deeply committed to developing companies and products that improve and save lives—an enduring passion that motivates him to build exceptional teams, processes, and systems that deliver meaningful impact.

David Esposito is an experienced health care executive who has built and scaled multiple companies, resulting in successful exits to strategic buyers. He is the former CEO of Armune BioScience, where he led the development and commercialization of blood-based diagnostics to improve the early detection of cancer. The company successfully launched the only non-PSA blood test to improve the detection of prostate cancer. Armune BioScience was sold to Exact Sciences (EXAS) in 2017. David was president of Phadia US Inc. (allergy and autoimmune diagnostics) and played a pivotal role in the sale of the business to Thermo Fisher Scientific (TMO) in 2011. He began his career as a sales representative with Merck & Co. Inc., rising through the ranks of sales, marketing and commercial strategy for the U.S. division. As a combat veteran, David led an infantry platoon with the 101st Airborne Division through several combat operations and was recognized with a Bronze Star for combat action in Iraq in 1991. He earned his bachelor’s degree in civil engineering from the U.S. Military Academy at West Point and his MBA from Syracuse University.

Dr. Alena Butkevica, MD, DMD, PhD, is an Oral and Maxillofacial Surgeon and specialist in Prosthodontics and Implantology with over 28 years of clinical experience and more than 15,000 surgical procedures performed; she is also the CEO and founder of AB BIOINNOVATIONS, Inc. (AB BIO), a U.S.-based biotechnology company developing science-backed products that reset, restore, and enhance the body’s natural regenerative abilities by improving circulation, releasing toxins, and accelerating healing—an approach rooted in Dr. Butkevica’s 19 years of scientific research in fast and healthy tissue regeneration.

Dr. Axa Yox is a former scientist turned transformational speaker, author, and LinkedIn strategist. With a PhD in Microbiology and Genetics and a career marked by international fellowships and groundbreaking research, she has authored over 45 scientific papers and holds 12 inventions. Now based in Miami, she’s the founder of X Theory, host of the W.H.Y. – What How Y podcast, and author of Foolfilled Life, a motivational guide to rewiring the brain to overcome anxiety and procrastination. A TEDx 2025 speaker-in-prep and executive contributor at BRAINZ Magazine, Axa brings deep scientific insight to personal development, branding, and the psychology of change.

Over the course of the last decade, first as a graduate student at Harvard University in the Department of Molecular and Cell Biology with PhD advisor Professor Stuart Schreiber and then as an independent postdoctoral fellow at the Lewis-Sigler Institute at Princeton University, Dr. Ethan Perlstein developed an approach to studying old drugs and discovering new drugs in model organisms called evolutionary pharmacology. Ethan is an author on 19 peer-reviewed scholarly publications, including the discovery of a novel mechanism of action for the antidepressant Zoloft based on studies in yeast cells.

Dr. Kevin Scanlon is a seasoned leader in life sciences, with a career spanning academic medicine, executive roles in biotech and pharma, and active angel investing. Recognized by LA Techweek for his impact on the Los Angeles tech and business landscape, he served as Chairman of the Pasadena Angels, where nearly 100 investors funded over 50 companies during his tenure. Dr. Scanlon has led four biotech companies as CEO, including Melanoma Diagnostics, acquired by Myriad Genetics. At Berlex-Schering AG, he oversaw global genomic and oncology programs across the US, Europe, and Asia. His academic credentials include being a Leukemia Society Scholar, recipient of the Paul Martini Medical Research Prize (Germany), and co-founding editor of Cancer Gene Therapy (Nature Publishing Group). He has served as President of the International Society of Cell and Gene Therapy and authored 139 peer-reviewed papers, nine medical books, and seven U.S. patents. Dr. Scanlon is also the author of The Hybrid Entrepreneur.

UBERDOC Founder and CEO Paula M. Muto, MD FACS, is a practicing vascular and general surgeon in solo practice and the owner of Muto Vein Center. She is a member of a family of physicians and surgeons who have collectively practiced medicine in Massachusetts for over 50 years. She is an outspoken advocate for patient care and is passionate about women’s health issues.

Ed Fleischer is a Quality Control executive with extensive experience leading quality improvement, operational excellence, and compliance initiatives in the biotechnology industry. He brings deep knowledge of biotechnology processes, quality systems, and both domestic and international regulatory requirements. Ed has a strong background in Quality and has worked closely with regulatory agencies including the FDA, EMA, and others. He is also a dedicated leader who prioritizes the development of staff at all levels of the organization.

Jessica Gibson is the CEO and Co-Founder of Ariel Precision Medicine, dedicated to delivering innovative technology to advance the art and science of Precision Medicine. Ariel leverages expert systems to accelerate precision medicine across the healthcare ecosystem by linking diagnostics and patient-centered data, uncovering the mechanisms of disease, and developing targeted treatments—fundamentally transforming patients' lives and outcomes. With a strong record of leadership, Jessica brings creative and solution-oriented problem-solving skills to accomplish strategic goals. At Ariel, she applies a broad range of experience across the pharmaceutical, biotechnology, clinical, and research sectors to develop scalable solutions for some of healthcare's most pressing challenges in chronic disease. Highly driven and grounded in a strong foundation of medical sales and marketing, Jessica is committed to collaborative engagement with diverse stakeholders, always with a patient-focused perspective.

Medical device sales professional that utilizes grit, achievement drive, and organization to achieve success and appropriate solutions for the customer. High achievement with highest revenue, President's Club, etc. Strong leadership skills and desire to facilitate the success of others.

Throughout her career, Kerchanin Allen has supported organizations ranging from startups to Fortune 50 companies in operationalizing their marketing and communications strategies, with a focus on compliance and sustainable growth. In her recent roles, she has emphasized leadership in developing comprehensive, health-centric, and value-based marketing strategies that drive success in post-acute care and align with broader business objectives. Kerchanin works collaboratively with cross-functional teams to refine brand storytelling and develop robust, data-driven content pillars and account-based marketing (ABM) strategies that resonate with target audiences and support growth-focused initiatives. Her expertise also extends to leveraging data analytics for campaign optimization and managing budgets to maximize ROI. With a strong command of digital, print, and media channels, along with a talent for cultivating key partnerships, she plays a vital role in advancing brand presence and market influence.

Len May is a pioneer in personalized wellness, combining over 25 years of experience in genomics, epigenetics, and the endocannabinoid system. As the CEO of EndoDNA, he leads the development of a patented platform that uses DNA to deliver personalized health insights, supported by the world’s largest real-world efficacy dataset. A global authority on medicinal cannabis and precision health, Len is also a published author, international speaker, and host of the podcast Everything is Personal. His books Making Cannabis Personal and ADD is a Superpower highlight his commitment to reshaping healthcare through personalization. Len’s work continues to shape the future of individualized medicine, making healthcare truly personal.

Mary Hames is a scientist-turned-strategic leader with over a decade of experience guiding biotech and pharma companies from breakthrough science to real-world impact. With deep expertise in neurology, rare diseases, and radiopharmaceuticals, Mary has held roles spanning R&D, medical affairs, diagnostics, and executive leadership. She specializes in translating complex science into strategic action—building scalable systems, aligning cross-functional teams, and accelerating development and launch readiness. Known for her clarity, energy, and execution, Mary thrives in high-stakes environments where innovation meets urgency.

Naomi Cosman is the Global Head of Marketing at Koning, where she leads the company’s overall marketing strategy, including PR, social media, creative, web, and campaign execution. With a double major in Communications and French from the University of Wisconsin-Madison, Naomi also holds marketing and business certificates from NYU and Harvard Business School. She brings over a decade of experience—five years at a Fortune 500 company in branding and campaign management, followed by five years with startups across various sectors. At Koning, Naomi partners with leadership to elevate brand awareness and public engagement, helping position the company as a leader in revolutionary women’s healthcare.

Real Rousseau is a seasoned business growth strategist with over 20 years of executive leadership experience spanning CEO, COO, and Business Development roles. He specializes in helping companies unlock revenue potential, streamline operations, and lead high-performing sales and marketing teams. Known for delivering measurable results—such as doubling revenue and boosting profit margins by 30% in just 12 months—Real combines strategic vision with operational expertise to drive sustainable business success.

Dr. Wendy Slone is the founder and CEO of bTECH Inc., where she leads the development of the Halcyon SMART Patch—a wearable healing technology designed to revolutionize chronic wound care. Inspired by her mother’s experience with diabetic ulcers, Dr. Slone combines personal passion with deep scientific expertise. She holds a Ph.D. in public policy, is pursuing a second doctorate in chemistry, and brings over 15 years of experience in data analytics and entrepreneurship. Her mission is clear: to transform outcomes for patients facing chronic wounds through innovation, science, and purpose-driven leadership.